Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation – TIMI 48 Primary Results Robert P. Giugliano, MD, SM, FAHA, FACC On behalf.
Georges Ghanem MD, FESC, FACC Associate Professor, Chief of Cardiology UMC-RH/LAU-SOM Beirut, Lebanon.
Patient-safety regarding the concomittant use of naturoceuticals and pharmaceuticals
The case for switching to the emerging oral anticoagulants in Atrial Fibrillation
DABIGATRAN in Daily Use: Facts & Opinions
